Thermo Fisher Adjusted EPS Rises 15% To $6.68 As Operating Margin Widens To 24.5%
Third-quarter revenue grew 9% to $12.14 billion, and the company said it would give updated 2026 guidance on its call.
Thermo Fisher Scientific's third-quarter revenue grew 9% to $12.14 billion, versus $11.12 billion a year earlier, according to an 8-K filed Wednesday. Adjusted earnings per share rose 15% to $6.68, and the company said it would update its 2026 guidance on its 7:00 a.m. Eastern call.
What the results show
Organic revenue growth, which strips out acquisitions, divestitures and currency, was 6%. Acquisitions and divestitures added 3 percentage points, and currency added nothing, the release shows.
Standard-accounting (GAAP) diluted earnings per share rose 9% to $4.64, from $4.27. Adjusted EPS was $6.68, against $5.79 a year earlier.
Adjusted operating income was $2.97 billion, 15% higher, and the adjusted operating margin widened to 24.5% from 23.3%. GAAP operating income was $2.26 billion, up 17%, with a GAAP margin of 18.6% versus 17.4%.
Free cash flow was $2.12 billion, against $1.84 billion in the year-ago quarter. For the first nine months, free cash flow was $4.62 billion versus $3.32 billion.
Buybacks, segments and the divestiture
The company spent $4.0 billion repurchasing its own stock in the first nine months, versus $2.96 billion in the same period of 2025. Acquisitions, net of cash acquired, were $8.88 billion over the nine months, versus $4.04 billion.
By segment, Laboratory Products and Biopharma Services was the largest, at $6.86 billion of revenue versus $5.97 billion. Specialty Diagnostics was the one segment with lower sales, at $1.10 billion versus $1.17 billion.
The company also said it completed its previously announced sale of its microbiology business during the quarter. Chairman and CEO Marc N. Casper called it "another excellent quarter."
What to watch
The release gives no 2026 guidance figures. The company said it would provide them on Wednesday's call, so the forecast is the next piece of news.
The guidance the company promised for Wednesday's call is the number that will show whether the quarter's 24.5% adjusted margin carries into the full year.
Sources
- 8-K Filing — THERMO FISHER SCIENTIFIC INC. (TMO) — SEC EDGAR
- Exhibit q32026earnings8kex99_1.htm — THERMO FISHER SCIENTIFIC INC. 8-K exhibit — SEC EDGAR
- Thermo Fisher Scientific (TMO) Stock Gets Fair Value Bump After Q2 Driven Analyst Target Increases — Yahoo Finance
- Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery — Yahoo Finance
- If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now — Yahoo Finance